← FDA Drug Approvals (Drugs@FDA)

SELEXIPAG

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2022-12-21

Drug application

FDA Application #

ANDA214302

Application type

Abbreviated New Drug Application (Generic)

Brand name

SELEXIPAG

Generic name

SELEXIPAG

Active ingredients

SELEXIPAG

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYDUS LIFESCIENCES

Manufacturer

Zydus Pharmaceuticals (USA) Inc.

First approval

2022-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown